Clinical Trial

Ketamine and Fentanyl to Treat Moderate to Severe Pain

Study Description

Sub-Dissociative Ketamine and Fentanyl to Treat Moderate to Severe Pain

The objective of this study is to evaluate the potential opioid-sparing effect associated with the novel combination of fentanyl and sub-dissociative ketamine in adult patients with moderate to severe pain in the emergency department.

Location

Locations Selected Location

Methods

Pharmaceutical medication involved Pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Drug - Fentanyl

1 mg/kg of Fentanyl IV administered over at least 1 minute

Combination Product - Fentanyl and Ketamine

Combined dose of 0.15 mg/kg of Sub-dissociative Ketamine and 0.5 mg/kg of Fentanyl IV administered over at least 1 minute.

Drug - Ketamine

0.3 mg/kg of Sub-Dissociative Ketamine IV administered over at least 1 minute

Additional Information

Official Study Title

A Combination Study With Sub-Dissociative Ketamine and Fentanyl to Treat Moderate to Severe Pain in the Emergency Department

Clinical Trial ID

NCT03959852

ParticipAid ID

bqxn7a